drugset / Trial / NCT02944201

Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate

NCT02944201

NaSingle-groupOpen-labelTreatment

Summary

This will be a single arm, window of opportunity study in men with treatment-naïve prostate cancer who will proceed to prostatectomy. Men will be treated with carvedilol prior to undergoing prostatectomy.

Timeline

Start
2017-04-01
Primary completion
2020-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 6.25 mg Oral

Indications